A list of downloadable documents created during development.
Final appraisal determination
Assessment report sent for information
Response to comments on scope and matrix
Equality impact assessment form
Diabetes (type 2) - canagliflozin, dapagliflozin and empagliflozin (monotherapy): draft scope (post-referral)
Diabetes (type 2) - canagliflozin, dapagliflozin and empagliflozin (monotherapy): provisional matrix (post-referral)